Brief: Diaxonhit receives $0.5 million payment from Allergan
July 21 (Reuters) - Diaxonhit SA ALEHT.PA :
* Receives $0.5 million payment from Allergan AGN.N
* Payment follows IND filing with the FDA for a molecule
derived from the collaboration between the two companies
Source text for Eikon: ID:nHUG71JPBB
Further company coverage: ALEHT.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million